Domov › Duševne motnje › Florida
Klinične študije za Duševne motnje v Florida
7 študij za Duševne motnje išče udeležence na lokacijah v Florida.
Mesta v Florida
Uradno besedilo študije (angleško)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Brandon, Florida, Brandon
- Miami, Florida, Miami
- Miami, Florida, Miami
- in še 5
Vključevanje udeležencevFaza 2/3
Starost 18–70 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07598708A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Boca Raton
- Clinical Site, Deerfield Beach
- Clinical Site, Doral
- in še 11
Vključevanje udeležencevFaza 2
Starost 55–90 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06887192A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Hollywood
- Clinical Site, Hollywood
- Clinical Site, Miami
- in še 2
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07459647A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- K2 Medical Research, LLC, Maitland
- Charter Research, LLC, The Villages
Vključevanje udeležencevFaza 1
Starost 50–85 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT06297590A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- CenExel, Hollywood
- Bioresearch Partner, Miami
- University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 11. maj 2026 · NCT06524830A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
- Vistagen Clinical Site, Largo
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 5. feb. 2026 · NCT06809179Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Maitland
- GSK Investigational Site, Miami
- GSK Investigational Site, Stuart
Vključevanje udeležencevFaza 2
Starost 50–85 · Vsi spoli · Posodobljeno 2. feb. 2026 · NCT07105709Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.